X-50607728-TTCCTCC-TTCC
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_020717.5(SHROOM4):c.3411_3413delGGA(p.Glu1138del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000299 in 1,111,158 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 64 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00043 ( 0 hom., 10 hem., cov: 14)
Exomes 𝑓: 0.00029 ( 0 hom. 54 hem. )
Consequence
SHROOM4
NM_020717.5 disruptive_inframe_deletion
NM_020717.5 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.943
Genes affected
SHROOM4 (HGNC:29215): (shroom family member 4) This gene encodes a member of the APX/Shroom family, which contain an N-terminal PDZ domain and a C-terminal ASD2 motif. The encoded protein may play a role in cytoskeletal architecture. Mutations in this gene have been linked to the X-linked Stocco dos Santos syndrome characterized by cognitive disabilities. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant X-50607728-TTCC-T is Benign according to our data. Variant chrX-50607728-TTCC-T is described in ClinVar as [Likely_benign]. Clinvar id is 590248.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 10 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SHROOM4 | NM_020717.5 | c.3411_3413delGGA | p.Glu1138del | disruptive_inframe_deletion | 6/9 | ENST00000376020.9 | NP_065768.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SHROOM4 | ENST00000376020.9 | c.3411_3413delGGA | p.Glu1138del | disruptive_inframe_deletion | 6/9 | 2 | NM_020717.5 | ENSP00000365188.2 | ||
SHROOM4 | ENST00000289292.11 | c.3411_3413delGGA | p.Glu1138del | disruptive_inframe_deletion | 6/10 | 1 | ENSP00000289292.7 | |||
SHROOM4 | ENST00000460112.3 | c.3063_3065delGGA | p.Glu1022del | disruptive_inframe_deletion | 5/8 | 5 | ENSP00000421450.1 |
Frequencies
GnomAD3 genomes AF: 0.000426 AC: 45AN: 105667Hom.: 0 Cov.: 14 AF XY: 0.000349 AC XY: 10AN XY: 28681
GnomAD3 genomes
AF:
AC:
45
AN:
105667
Hom.:
Cov.:
14
AF XY:
AC XY:
10
AN XY:
28681
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000598 AC: 76AN: 127114Hom.: 0 AF XY: 0.000184 AC XY: 6AN XY: 32658
GnomAD3 exomes
AF:
AC:
76
AN:
127114
Hom.:
AF XY:
AC XY:
6
AN XY:
32658
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000285 AC: 287AN: 1005455Hom.: 0 AF XY: 0.000179 AC XY: 54AN XY: 301399
GnomAD4 exome
AF:
AC:
287
AN:
1005455
Hom.:
AF XY:
AC XY:
54
AN XY:
301399
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000426 AC: 45AN: 105703Hom.: 0 Cov.: 14 AF XY: 0.000348 AC XY: 10AN XY: 28729
GnomAD4 genome
AF:
AC:
45
AN:
105703
Hom.:
Cov.:
14
AF XY:
AC XY:
10
AN XY:
28729
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2015 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
SHROOM4-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 01, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2024 | SHROOM4: BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at